about
The effect of transcranial magnetic stimulation on movement selectionElevated homocysteine by levodopa is detrimental to neurogenesis in parkinsonian modelNeuroanatomical heterogeneity of essential tremor according to propranolol responsePersistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter ImagingUnilateral standing leg tremor as the initial manifestation of Parkinson disease.Mesenchymal stem cells can modulate longitudinal changes in cortical thickness and its related cognitive decline in patients with multiple system atrophy.Comparison of endothelial progenitor cells in Parkinson's disease patients treated with levodopa and levodopa/COMT inhibitor.A randomized trial of mesenchymal stem cells in multiple system atrophy.Apathy and olfactory dysfunction in early Parkinson's disease.Current status of Parkinson's disease treatment in Korea.Patterns of Neuropsychological Profile and Cortical Thinning in Parkinson's Disease with Punding.Gender Differences in Age-Related Striatal Dopamine Depletion in Parkinson's DiseaseComparison of regional brain atrophy and cognitive impairment between pure akinesia with gait freezing and Richardson's syndrome.Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease.Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans.Different modulation of the cortical silent period by two phases of short interval intracortical inhibition.Use of the Putamen/Caudate Volume Ratio for Early Differentiation between Parkinsonian Variant of Multiple System Atrophy and Parkinson DiseaseFactors related to outcomes of subthalamic deep brain stimulation in Parkinson's diseaseThe MMSE and MoCA for Screening Cognitive Impairment in Less Educated Patients with Parkinson's Disease.Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease.Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.Sleep Disturbance May Alter White Matter and Resting State Functional Connectivities in Parkinson's Disease.Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease.A prognostic factor in focal hand dystonia: typist's cramp cases and literature review.Familiar Hyperekplexia, a Potential Cause of Cautious Gait: A New Korean Case and a Systematic Review of Phenotypes.Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy.Cognitive and Neuroanatomical Correlates in Early Versus Late Onset Parkinson's Disease Dementia.Hyperhomocysteinemia in patients with Parkinson's disease and relationship to vitamin B level.Does education modify motor compensation in Parkinson's disease?Is Dominant-Side Onset Associated With a Better Motor Compensation in Parkinson's Disease?Nigrostriatal dopamine-independent resting-state functional networks in Parkinson's disease.Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease.Sleepiness and Depression in Parkinson's Disease Patients Treated with Ropinirole and Levodopa.Is progressive upper-body apraxia a corticobasal syndrome?A case-control study of multiple system atrophy in Korean patients.Effect of levetiracetam on human corticospinal excitability.Cerebral microbleeds in patients with Parkinson's disease.The pattern of cortical atrophy in Parkinson's disease with mild cognitive impairment according to the timing of cognitive dysfunction.
P50
Q24671913-2F512A36-274B-474D-A1E1-7AC900DFA3C6Q27334004-20BF8C60-DC85-4D85-8247-2EC0968541A9Q28537630-2A7205E4-7432-4133-BB90-A304F6327B9EQ28550219-B37D922F-73DC-470B-8031-72D1726462EDQ33636351-0450151E-2DEF-41A7-8ADB-C5D08F01C896Q33750881-BEF08FC5-BECC-4815-9476-761A32FF8B0BQ33955006-08B98802-C3BA-49D0-BB7A-93993F2F5446Q34290126-E57A3F55-2EA3-495F-92DA-253706268E0AQ34983745-F9038575-0C36-4F96-B511-3BF43D35883AQ35198079-DCBE4186-4944-41F3-949C-48B4150FD6CAQ35720321-F24EB780-6E1D-4443-80AE-66F47CA98553Q36067225-47E15E95-FB04-437E-8CFA-DF35D2377C2EQ36101266-73F2DA54-94D7-4C64-8D79-05FE279621CAQ36104787-1B80848F-910E-4B78-BC71-8069EDC7ADCBQ36526295-E2E99377-9D8F-4C69-85AE-87F22D9432FCQ37065600-52234D24-1CCC-4E76-8900-CBB6666971B7Q37203289-DD8FD97B-2009-44E0-A2C5-3E237607923EQ37258415-889EB84C-D024-420B-84EF-11E49F8D2D66Q37281719-47CA9827-77BD-4812-B3CE-A122811D13F5Q38373440-3A689494-6952-491A-A3F6-8D8F489F03EBQ38397112-5213B56C-0C6E-4CDF-BA67-2037FD45DA17Q38404255-701A243E-A3BF-4946-8A1F-1FD9FC842920Q38427219-E51BD016-C405-479D-A545-A757FA4CB1D4Q38433850-2A393FE2-31FB-4786-884C-CAF334A5578DQ38436637-603348A3-8EF4-4142-BFAD-C417105CDE5BQ39015726-9563CA1D-03F9-4609-A318-6F9492F9C4B0Q39103207-0C4E71B0-090A-447A-B17D-CA3F4E0E6C37Q39284058-D231DCCB-0824-48AE-BEBA-76BD5C91341EQ39357746-1166E70A-FC33-4FFB-891A-87CE420F4193Q39784593-952B6990-482D-4A8F-8CF4-98078518BBBDQ39947392-75BC0498-1F7E-4835-94F8-C38711FCF60DQ40499580-9B10AE01-C6D1-4064-926E-02657C992837Q40768407-A2C9D9A9-F52A-412A-9DA9-44E0FEE66910Q41388634-E658EDD3-4A0D-4AD4-A5D4-E3A8D75BC3CBQ41675120-4F160AEC-9E38-453B-A0A9-C98B01D2769CQ42516082-0F355DF7-1C8F-4C2B-B777-8A127350C817Q42972814-1B2B069F-028A-41FF-B92C-770E42E103D0Q43734079-C7A0A031-E8BF-44B9-9236-19FEC1D3BE69Q44012399-594AE54F-660D-4418-B0E9-EF67957E2808Q44012710-F388DAAD-E467-494C-9F24-D1F4BC87793F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Young H. Sohn
@ast
Young H. Sohn
@en
Young H. Sohn
@es
Young H. Sohn
@nl
type
label
Young H. Sohn
@ast
Young H. Sohn
@en
Young H. Sohn
@es
Young H. Sohn
@nl
altLabel
Young Ho Sohn
@en
prefLabel
Young H. Sohn
@ast
Young H. Sohn
@en
Young H. Sohn
@es
Young H. Sohn
@nl
P106
P31
P4012
P496
0000-0001-6533-2610